<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7128395\results\search\drugs\results.xml">
  <result pre="5 of the patients with CKD) received antiviral therapy and" exact="hydroxychloroquine" post="as per our protocol. Dexamethasone and tocilizumab have been"/>
  <result pre="antiviral therapy and hydroxychloroquine as per our protocol. Dexamethasone and" exact="tocilizumab" post="have been used, respectively, in 11 and 6 of"/>
  <result pre="effect, and antiviral drugs may be considered (e.g., chloroquine-hydroxychloroquine, lopinavir/ritonavir," exact="darunavir" post="ritonavir, and darunavir/cobicistat). The second phase of the disease"/>
  <result pre="evidence seems to support the role of antiviral activity of" exact="chloroquine" post="toward the SARS and avian influenza viruses in in"/>
  <result pre="molecular structure, a well-known immunomodulating effect,10 and better safety profile," exact="hydroxychloroquine" post="may be considered as an option in this context,11"/>
  <result pre="study performed on patients with COVID-19 infection and treated with" exact="hydroxychloroquine" post="demonstrated that combination with azithromycin was associated with a"/>
  <result pre="COVID-19 infection and treated with hydroxychloroquine demonstrated that combination with" exact="azithromycin" post="was associated with a higher probability of showing a"/>
  <result pre="the therapy compared with controls and with those who received" exact="hydroxychloroquine" post="alone.12 Corticosteroids The use of corticosteroids would be contraindicated"/>
  <result pre="to have in the development of the cytokine release syndrome,17" exact="tocilizumab" post="could play a role in the management of selected"/>
  <result pre="During this phase, treatment with glucocorticoid and the interleukin-6 inhibitor" exact="tocilizumab" post="should be considered, especially in patients with rapid clinical"/>
  <result pre="2019 pandemic and kidneys. Kidney Int, in press. 7WangM.CaoR.ZhangL.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="of Guangdong Province and Health Commission of Guangdong Province for" exact="chloroquine" post="in the treatment of novel coronavirus pneumonia[Expert consensus on"/>
  <result pre="chloroquine in the treatment of novel coronavirus pneumonia[Expert consensus on" exact="chloroquine" post="phosphate for the treatment of novel coronavirus pneumonia]Zhonghua Jie"/>
  <result pre="al. A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19 [e-pub ahead of print]."/>
  <result pre="https://doi.org/10.1016/j.jcrc.2020.03.005. Accessed March 23, 2020. 10van den BorneB.E.DijkmansB.A.de RooijH.H.Chloroquine and" exact="hydroxychloroquine" post="equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma"/>
  <result pre="Tong Q. COVID-19: a recommendation to examine the effect of" exact="hydroxychloroquine" post="in preventing infection and progression [e-pub ahead of print]."/>
  <result pre="12Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 </snippets>
</snippetsTree>
